58. For adults with septic shock and an ongoing requirement for vasopressor therapy we suggest using IV corticosteroids
其他疗法
糖皮质激素
58.对于感染性休克且持续需要血管收缩药升压治疗的成人,我们建议使用静脉注射糖皮质激素。
59. For adults with sepsis or septic shock, we suggest against using polymyxin B haemoperfusion
59.对于患有脓毒症或脓毒性休克的成人,我们建议不要使用多粘菌素B血液灌流。
60. There is insufficient evidence to make a recommendation on the use of other blood purification techniques
60.没有足够的证据推荐使用其他血液净化技术。
61. For adults with sepsis or septic shock, we recommend using a restrictive (over liberal) transfusion strategy
61.对于患有脓毒症或脓毒性休克的成人,我们建议使用限制性(而不是开放性)输血策略。
62. For adults with sepsis or septic shock, we suggest against using intravenous immunoglobulins
62.对于成人脓毒症或脓毒性休克,我们建议不要使用静脉注射免疫球蛋白。
63. For adults with sepsis or septic shock, and who have risk factors for gastrointestinal (GI) bleeding, we suggest using stress ulcer prophylaxis 63.对于患有脓毒症或脓毒性休克的成年人,以及有胃肠道出血危险因素的成年人,我们建议预防应激性溃疡。
For adults with sepsis or septic shock, we recommend using pharmacologic VTE prophylaxis unless a contraindication to such therapy exists
对于患有脓毒症或脓毒性休克的成人,我们建议使用药物预防VTE预防,除非存在此类治疗的禁忌症。
65. For adults with sepsis or septic shock, we recommend using low molecular weight heparin (LMWH) over unfractionated heparin (UFH) for VTE prophylaxis
65.对于成人脓毒症或脓毒性休克,我们建议使用低分子量肝素(LMWH)而非普通肝素(UFH)预防VTE。
66. For adults with sepsis or septic shock, we suggest against using mechanical VTEprophylaxis in addition to pharmacological prophy laxis, over pharmacologic prophylaxis alone 66.对于患有脓毒症或脓毒性休克的成人,我们建议不要在药物预防的基础上再使用机械预防VTE。
67. In adults with sepsis or septic shock and AKI who require renal replacement therapy, we suggest using either continuous or intermittent renal replacement therapy
67.对于需要肾脏替代治疗的成人脓毒症或脓毒性休克和AKI患者,我们建议使用连续或间断肾脏替代治疗。
68. In adults with sepsis or septic shock and AKI, with no definitive indications for renal replacement therapy, we suggest against using renal replacement therapy
68.对于患有脓毒症或脓毒性休克和AKI的成人,没有明确的肾脏替代治疗指征,我们建议不要使用肾脏替代治疗
69. For adults with sepsis or septic shock, we recommend initiating insulin therapy at a glucose level of ≥ 180 mg/dL (10 mmol/L) 69.对于患有脓毒症或脓毒性休克的成人,我们建议在血糖水平≥ 180 mg/dL (10 mmol/L)时开始胰岛素治疗。
70.Weak recommendation, low quality of evidence
70.对于患有败血症或脓毒性休克的成人,我们建议不要静脉注射维生素C。
71. For adults with septic shock and hypoperfusioninduced lactic acidemia, we suggest against using sodium bicarbonate therapy to improve haemodynamics or to reduce vasopressor requirements
71.对于感染性休克和低灌注诱导的乳酸血症的成人,我们建议不要使用碳酸氢钠治疗来改善血液动力学或减少血管加压药的需求
72. For adults with septic shock, severe metabolic acidemia (pH ≤ 7.2) and AKI (AKIN score 2 or 3), we suggest using sodium bicarbonate therapy
72.对于感染性休克、严重代谢性酸血症(pH ≤ 7.2)和AKI (AKIN评分2或3)的成人,我们建议使用碳酸氢钠治疗。
73. For adult patients with sepsis or septic shock who can be fed enter ally, we suggest early (within 72 h) initiation of enteral nutrition
73.对于可以肠内喂养的成人脓毒症或脓毒性休克患者,我们建议早期(72小时内)开始肠内营养
74. For adults with sepsis or septic shock, we recommend discussing goals of care and prognosis with patients and families over no such discussion
74.对于患有脓毒症或脓毒性休克的成人,我们建议与患者和家属讨论治疗和预后目标。
75. For adults with sepsis or septic shock, we suggest addressing goals of care early (within 72 h) over late
75.对于患有脓毒症或脓毒性休克的成人,我们建议尽早(72小时内)关注治疗目标。
77. For adults with sepsis or septic shock, we recommend integrating principles of palliative care (which may include palliative care consultation based on clinician judgement) into the treatment plan, when appropriate, to address patient and family symptoms and suffering
77.对于患有脓毒症或脓毒性休克的成人,我们建议在适当的时候将姑息治疗的原则(可能包括基于临床医生判断的姑息治疗咨询)纳入治疗计划,以解决患者和家属的症状和痛苦。
82. For adults with sepsis or septic shock and their families, we recommend screening for economic and social support (including housing, nutritional, financial, and spiritual support), and make referrals where available to meet these needs Best Practice Statement 82.对于患有脓毒症或脓毒性休克的成年人及其家人,我们建议筛查经济和社会支持(包括住房、营养、经济和精神支持),并在可行的情况下进行转诊以满足这些需求。
83. For adults with sepsis or septic shock and their families, we suggest offering written and verbal sepsis education (diagnosis, treatment, and post ICU/post sepsis syndrome) prior to hospital discharge and in the followup setting 83.对于患有脓毒症或脓毒性休克的成人及其家属,我们建议在出院前和随访期间提供书面和口头的脓毒症教育(诊断、治疗和ICU后/脓毒症后综合征)。
84. For adults with sepsis or septic shock and their families, we recommend the clinical team provide the opportunity to participate in shared decision making in postICU and hospital discharge planning to ensure discharge plans are acceptable and feasible
84.对于患有脓毒症或脓毒性休克的成人及其家属,我们建议临床团队提供其参与共同决策转出ICU和出院后计划的机会,以确保出院计划是可接受的和可行的。
85. For adults with sepsis and septic shock and their families, we suggest using a critical care transition programme, compared to usual care, upon transfer to the floor 85.对于患有败血症和感染性休克的成年人及其家人,我们建议在转移到基层时采用危重病治疗过渡方案,而不是常规治疗方案。
86. For adults with sepsis and septic shock, we recommend reconciling medications at both ICU and hospital discharge
86.对于成人败血症和感染性休克,我们建议在转出ICU和出院时调整药物治疗。
87. For adult survivors of sepsis and septic shock and their families, we recommend including information about the ICU stay, sepsis and related diagnoses, treatments, and common impairments after sepsis in the written and verbal hospital discharge summary 87.对于脓毒症和脓毒性休克的成年幸存者及其家人,我们建议在书面和口头出院总结中包括关于ICU住院时间、脓毒症和相关诊断、治疗以及脓毒症后常见功能损伤的信息。
88. For adults with sepsis or septic shock who developed new impairments, we recommend hospital discharge plans include followup with clinicians able to support and manage new and longterm sequelae
88.对于新发器官功能损害的成人脓毒症或脓毒性休克患者,我们建议出院计划中包括对临床医生的随诊,随诊的医生应具备支持和处理新的长期后遗症的能力。
90. There is insufficient evidence to make a recommendation on early cognitive therapy for adult survivors of sepsis or septic shock
90.没有足够的证据建议对脓毒症或脓毒性休克的成年幸存者提出早期认知治疗
91. For adult survivors of sepsis or septic shock, we recommend assess ment and followup for physical, cognitive, and emotional problems after hospital discharge
91.对于脓毒症或脓毒性休克的成年幸存者,我们建议出院后对身体、认知和情绪问题进行评估和随访。